Colgate-Palmolive (CL) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
January 30, 2026 6:55 AM ESTNEW YORK--(BUSINESS WIRE)-- Colgate-Palmolive Company (NYSE: CL):
Full Year
Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share... More
